Vol 2016, No 6 (2016)

Table of Contents

Research & Development

Celgene Spreads its Bets in Immuno-Oncology via New Deal with Agios Abstract pdf html
Natasha Berry & Heather Cartwright

Licensing

Janssen Biotech Secures Another DART Molecule in US$740 M Deal with MacroGenics Abstract html pdf
Jawala Prasad & Heather Cartwright
Biogen Revamps its Outlook by Licensing Next Generation Gene Therapies Abstract pdf html
Jasmine Kalsi

Mergers & Acquisitions

Pfizer Returns to Deal Making with Anacor Acquisition Abstract pdf html
Rohit Khera
Merck & Co’s Neurology Boost with Afferent Acquisition Abstract html pdf
Keshav Mahawar
Promising AML Therapy Draws Jazz to US$1.5 B Acquisition of Celator Abstract pdf html
Jasmine Kalsi & Heather Cartwright


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.